| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $114.5M | — | -0.3% |
| Cost of Revenue | $33.7M | — | -37.2% |
| Gross Profit | $80.8M | — | +32.2% |
| R&D Expense | $2.6M | — | +214.4% |
| SG&A Expense | $26.7M | — | +11.1% |
| Operating Income | $58.3M | — | +67.1% |
| Pre-tax Income | $57.1M | — | +70.8% |
| Income Tax | $11.8M | — | +80.2% |
| Net Income | $45.3M | — | +68.5% |
| EPS (Basic) | $0.19 | — | +72.7% |
| EPS (Diluted) | $0.19 | — | +72.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $138.2M | +57.7% | +92.9% |
| Accounts Receivable | $135.9M | -14.2% | +36.7% |
| Inventory | $222.1M | +7.6% | +29.0% |
| Current Assets | $511.2M | +9.6% | +45.3% |
| Total Assets | $665.2M | +6.6% | +30.3% |
| Current Liabilities | $73.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $58.2M | — | +396.1% |
| Capital Expenditures | $2.5M | — | -45.9% |
| Investing Cash Flow | $2.4M | — | +150.9% |
| Financing Cash Flow | -$10.1M | — | -42.1% |
| Free Cash Flow | $55.7M | — | +328.5% |
| +37.5% |
| Long-term Debt | $196.9M | +172.9% | — |
| Total Liabilities | $274.9M | +87.1% | +100.4% |
| Stockholders' Equity | $390.3M | -18.2% | +4.5% |